Mycobacterium bovis BCG promotes tumor cell survival from tumor necrosis factor-α-induced apoptosis

Abstract

BackgroundIncreased incidence of lung cancer among pulmonary tuberculosis patients suggests mycobacteria-induced tumorigenic response in the host. The alveolar epithelial cells, candidate cells that form lung adenocarcinoma, constitute a niche for mycobacterial replication and infection. We thus explored the possible mechanism of M. bovis Bacillus Calmette-Guérin (BCG)-assisted tumorigenicity in type II epithelial cells, human lung adenocarcinoma A549 and other cancer cells.MethodsCancer cell lines originating from lung, colon, bladder, liver, breast, skin and cervix were treated with tumor necrosis factor (TNF)-α in presence or absence of BCG infection. p53, COP1 and sonic hedgehog (SHH) signaling markers were determined by immunoblotting and luciferase assays, and quantitative real time PCR was done for p53-responsive pro-apoptotic genes and SHH signaling markers. MTT assays and Annexin V staining were utilized to study apoptosis. Gain- and loss-of-function approaches were used to investigate the role for SHH and COP1 signaling during apoptosis. A549 xenografted mice were used to validate the contribution of BCG during TNF-α treatment.ResultsHere, we show that BCG inhibits TNF-α-mediated apoptosis in A549 cells via downregulation of p53 expression. Substantiating this observation, BCG rescued A549 xenografts from TNF-α-mediated tumor clearance in nude mice. Furthermore, activation of SHH signaling by BCG induced the expression of an E3 ubiquitin ligase, COP1. SHH-driven COP1 targeted p53, thereby facilitating downregulation of p53-responsive pro-apoptotic genes and inhibition of apoptosis. Similar effects of BCG could be shown for HCT116, T24, MNT-1, HepG2 and HELA cells but not for HCT116 p53-/- and MDA-MB-231 cells.ConclusionOur results not only highlight possible explanations for the coexistence of pulmonary tuberculosis and lung cancer but also address probable reasons for failure of BCG immunotherapy of cancers.Electronic supplementary materialThe online version of this article (doi:10.1186/1476-4598-13-210) contains supplementary material, which is available to authorized users.

Interleukin-13 interferes with activation-induced t-cell apoptosis by repressing p53 expression

“…30 TNF-a is one of the inducers of apoptosis 31 and functions by suppressing p53. 32 The present data show that IL-13 also suppresses caspase 3 and TNF-a in the CD4…”

The mycobacterial phosphatase PtpA regulates the expression of host genes and promotes cell proliferation

“…It has been previously reported that lung carcinogenesis can be induced by chronic TB infection in a mouse model 49 , and that BCG can promote the survival of A549 and several other tumor cells from TNFα-induced apoptosis thereby promoting tumorigenesis in xenograft studies 50 . Furthermore, Mtb-infected THP-1 cells can induce epithelial mesenchymal transition (EMT) in the lung adenocarcinoma epithelial cell line A549 51 .…”

Tumor-Associated Macrophages: Recent Insights and Therapies

“…Researchers enhance macrophage cytotoxicity through specificity to stimulate activation, such as by adding M-CSF and muramyl dipeptide (MDP) when macrophages are cultured in vitro to enhance macrophage cytotoxicity; by using the adoptive transfer treatment to achieve anti-tumor effects; or by using intravenous liposomes that load immune modulators to enhance the toxicity of macrophages. The molecules of microbial agents and pathogens can stimulate the antitumor cytotoxicity of macrophages, such as using bacilli calmette-guerin (BCG) in the treatment of bladder cancer, through stimulating macrophages to increase the cytotoxicity of macrophages to certain bladder cancer cell lines (55). In addition, there is evidence that the increased levels of IL-6, IL-12, and TNF in the urine of bladder cancer patients treated with BCG may be related to the enhancement of the function of macrophages.…”